Lolli, C., Verde, A., Degli Esposti, L., Acciai, V., Brigido, A., Proietti, E. and Scagliarini, S. 2024. Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases. Global and Regional Health Technology Assessment. 11, 1 (Jul. 2024), 154–160. DOI:https://doi.org/10.33393/grhta.2024.2892.